Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Polymeric Micelles in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
NCT07662746Phase 2Recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Jul 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in head and neck squamous cell carcinoma (HNSCC), sponsored by Shanghai Ninth People's Hospital. Started Jul 2026; status: recruiting.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT07662746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07662746.